BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 9619259)

  • 1. FDA recognition of consensus standards in the premarket notification program.
    Marlowe DE; Phillips PJ
    Biomed Instrum Technol; 1998; 32(3):301-4. PubMed ID: 9619259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA use of international standards in the premarket review process.
    Rechen E; Barth DJ; Marlowe D; Kroger L
    Biomed Instrum Technol; 1998; 32(5):518-26. PubMed ID: 9800008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and recognition of consensus standards in US premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Mar; 10(2):13-7. PubMed ID: 10387610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA Modernization Act of 1997: modifications to the list of recognized standards; availability; withdrawal of draft guidance "Use of IEC 60601 standards; medical electrical equipment"--FDA. Notice.
    Fed Regist; 1998 Oct; 63(200):55617-30. PubMed ID: 10185835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
    Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
    Yin L
    J Reprod Med; 1983 Jan; 28(1):3-11. PubMed ID: 6834344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New FDA draft guidance on premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Oct; 10(8):12-4. PubMed ID: 10724773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of standards in the review of medical devices.
    Ho C; Jensen D; Lacy F; Muni N; Reilly S; Mallis E
    J Electrocardiol; 2005 Oct; 38(4 Suppl):171-4. PubMed ID: 16226095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA regulation of invasive neural recording electrodes: a daunting task for medical innovators.
    Welle C; Krauthamer V
    IEEE Pulse; 2012 Mar; 3(2):37-41. PubMed ID: 22481744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; device tracking; new orders to manufacturers--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10638-40. PubMed ID: 10177504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oversight overhaul: eliminating the premarket review of medical devices and implementing a provider-centered postmarket surveillance strategy.
    Scott B
    Food Drug Law J; 2011; 66(3):377-404, ii. PubMed ID: 24505854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; implementation of third party review under the Food and Drug Administration Modernization Act of 1997; emergency processing request under OMB review--FDA. Notice.
    Fed Regist; 1998 May; 63(99):28388-91. PubMed ID: 10179874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA modernization act of 1997: guidance on medical device tracking; availability--FDA. Notice.
    Fed Regist; 1998 Mar; 63(42):10640-1. PubMed ID: 10177505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The U.S. Food and Drug Administration's role in improving radiation dose management for medical X-ray imaging devices.
    Miller DL; Kakar S; Jiang L; Spelic DC; Burk L
    Br J Radiol; 2021 Oct; 94(1126):20210373. PubMed ID: 33989043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.